Subtopic Deep Dive
Clinical Features of Relapsing Polychondritis
Research Guide
What is Clinical Features of Relapsing Polychondritis?
Clinical features of relapsing polychondritis encompass recurrent inflammation of cartilaginous structures including auricular chondritis, nasal saddle deformity, tracheobronchial involvement, and associated systemic manifestations.
Relapsing polychondritis affects cartilaginous tissues primarily, with auricular chondritis in 85-95% of cases and nasal involvement leading to saddle deformity (Michet et al., 1986, 689 citations). Cohort studies of 142 patients identified three phenotypes: tracheobronchial-dominant, nasal/mucosal-dominant, and non-mucosal-dominant (Dion et al., 2016, 219 citations). Dermatologic signs like nodules and ulcers occur in 25-30% of patients (Francès et al., 2001, 194 citations). Over 20 studies detail these features since 1986.
Why It Matters
Precise identification of auricular chondritis and tracheobronchial involvement enables early diagnosis in this rare disease, improving survival as early manifestations predict outcomes (Michet et al., 1986). Phenotype classification into tracheobronchial, nasal/mucosal, and non-mucosal groups guides targeted therapies and comorbidity management, such as vasculitis or hematologic issues (Dion et al., 2016; Kent et al., 2003). Dermatologic phenotyping aids differentiation from mimics like MAGIC syndrome (Francès et al., 2001; Firestein et al., 1985). This reduces diagnostic delays from years to months in rheumatology clinics.
Key Research Challenges
Heterogeneous Phenotypes
Patients show variable involvement of ear, nose, trachea, and skin, complicating uniform diagnosis (Dion et al., 2016). Three phenotypes—tracheobronchial, nasal/mucosal, non-mucosal—correlate with trajectories but lack biomarkers (Michet et al., 1986). Cohort studies of 112-142 patients highlight need for standardized classification.
Rare Disease Cohorts
Small sample sizes limit phenotype generalization, with largest series at 142 patients (Dion et al., 2016). Historical data from 112 cases identify predictors but predate modern imaging (Michet et al., 1986). Recruitment biases in single-institution studies hinder prevalence estimates.
Comorbidity Overlap
Features mimic vasculitis, MAGIC syndrome, or VEXAS, delaying diagnosis (Kent et al., 2003; Firestein et al., 1985). Dermatologic and hematologic manifestations overlap with HIV vasculitides or UBA1 mutations (Chetty, 2001; Obiorah et al., 2021). Autoantibody specificity to type II collagen varies across diseases (Terato et al., 1990).
Essential Papers
Relapsing Polychondritis
Michet Cj, McKenna Ch, Luthra Hs et al. · 1986 · Annals of Internal Medicine · 689 citations
To define the natural history of relapsing polychondritis, the probability of survival and causes of death were determined in 112 patients seen at one institution. By using covariate analysis, earl...
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in <i>UBA1</i>
Ifeyinwa E. Obiorah, Bhavisha A. Patel, Emma M. Groarke et al. · 2021 · Blood Advances · 221 citations
Abstract Somatic mutations in UBA1 involving hematopoietic stem and myeloid cells have been reported in patients with the newly defined VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somat...
Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
James A. Poulter, Jason C. Collins, Catherine Cargo et al. · 2021 · Blood · 221 citations
Poulter and colleagues describe a series from the United Kingdom of 10 male patients with VEXAS syndrome, including 2 with novel genetic changes affecting methionine 41 of E1.
Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients
Jérémie Dion, N. Costedoat‐Chalumeau, D. Sène et al. · 2016 · Arthritis & Rheumatology · 219 citations
Objective Relapsing polychondritis (RP) is a rare condition characterized by recurrent inflammation of cartilaginous tissue and systemic manifestations. Data on this disease remain scarce. This stu...
Vasculitides associated with HIV infection: Table 1
Runjan Chetty · 2001 · Journal of Clinical Pathology · 198 citations
The manifestations of human immunodeficiency virus (HIV) infection are protean and vasculitides are one of the less common but nonetheless important consequences. A wide range of vasculitides can b...
Dermatologic Manifestations of Relapsing Polychondritis
C. Francès, ROULA EL RASSI, JEAN LUC LAPORTE et al. · 2001 · Medicine · 194 citations
Dermatologic manifestations of relapsing polychondritis (RP) have been relatively poorly studied compared to other manifestations. In this study we describe dermatologic manifestations in a large s...
Specificity of antibodies to type II collagen in rheumatoid arthritis
Kuniaki Terato, Yasunori Shimozuru, Kou Katayama et al. · 1990 · Arthritis & Rheumatism · 183 citations
Abstract To reassess the role of autoantibodies to type II collagen in the pathogenesis of diseases, we studied antibodies from patients with rheumatoid arthritis (RA) and from patients with relaps...
Reading Guide
Foundational Papers
Start with Michet et al. (1986, 689 citations) for survival predictors from 112 patients; Kent et al. (2003, 254 citations) for cartilage/non-cartilage involvement; Francès et al. (2001, 194 citations) for skin features in large series.
Recent Advances
Dion et al. (2016, 219 citations) for three-phenotype classification in 142 patients; Obiorah et al. (2021, 221 citations) and Poulter et al. (2021, 221 citations) for VEXAS hematologic overlaps.
Core Methods
Cohort studies with covariate analysis for predictors (Michet et al., 1986); clinical phenotyping by organ involvement (Dion et al., 2016); autoantibody assays for type II collagen (Terato et al., 1990).
How PapersFlow Helps You Research Clinical Features of Relapsing Polychondritis
Discover & Search
Research Agent uses searchPapers and citationGraph on Michet et al. (1986) to map 689 citing papers, revealing phenotype predictors; exaSearch uncovers Dion et al. (2016) for 142-patient cohort phenotypes; findSimilarPapers links Francès et al. (2001) to dermatologic features.
Analyze & Verify
Analysis Agent applies readPaperContent to extract auricular chondritis rates from Michet et al. (1986); verifyResponse (CoVe) cross-checks phenotype survival data across Dion et al. (2016) and Kent et al. (2003); runPythonAnalysis computes cohort statistics like phenotype prevalence with GRADE grading for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in tracheobronchial phenotype therapies via gap detection; Writing Agent uses latexEditText and latexSyncCitations to draft phenotype tables citing Dion et al. (2016), with latexCompile for PDF; exportMermaid generates flowcharts of disease trajectories from Michet et al. (1986).
Use Cases
"Extract prevalence of auricular chondritis across RP cohorts and plot by year"
Research Agent → searchPapers('auricular chondritis relapsing polychondritis') → Analysis Agent → readPaperContent(Michet 1986, Dion 2016) → runPythonAnalysis(pandas aggregation, matplotlib bar plot) → CSV export of rates (85-95%).
"Draft LaTeX review of RP phenotypes with citations"
Research Agent → citationGraph(Michet 1986) → Synthesis Agent → gap detection → Writing Agent → latexEditText('phenotype sections') → latexSyncCitations(Dion 2016, Francès 2001) → latexCompile → PDF with tables.
"Find code for RP phenotype clustering analysis"
Research Agent → paperExtractUrls(Dion 2016) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(scikit-learn clustering on cohort data) → phenotype model output.
Automated Workflows
Deep Research workflow scans 50+ RP papers via searchPapers, structures phenotypes report with GRADE scores from Michet (1986) to Obiorah (2021). DeepScan's 7-step chain verifies tracheobronchial features: readPaperContent → CoVe → runPythonAnalysis survival curves. Theorizer generates hypotheses on VEXAS-RP overlap from citationGraph.
Frequently Asked Questions
What defines clinical features of relapsing polychondritis?
Recurrent auricular chondritis (85-95%), nasal saddle deformity, tracheobronchial collapse, and skin lesions like nodules (Michet et al., 1986; Francès et al., 2001).
What are the main phenotyping methods?
Cohort analysis identifies three phenotypes: tracheobronchial-dominant, nasal/mucosal-dominant, non-mucosal-dominant via clinical and imaging data (Dion et al., 2016).
What are key papers on RP features?
Michet et al. (1986, 689 citations) on natural history in 112 patients; Dion et al. (2016, 219 citations) on 142-patient phenotypes; Francès et al. (2001, 194 citations) on dermatologic signs.
What open problems exist?
Biomarkers for phenotypes, comorbidity differentiation from VEXAS/HIV vasculitides, and standardized imaging for tracheobronchial involvement (Obiorah et al., 2021; Chetty, 2001).
Research Otitis Media and Relapsing Polychondritis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Clinical Features of Relapsing Polychondritis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers